ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 65 filers reported holding ACORDA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 14.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $8,000 | +33.3% | 11,315 | 0.0% | 0.00% | – |
Q3 2020 | $6,000 | -60.0% | 11,315 | -46.9% | 0.00% | – |
Q2 2020 | $15,000 | -25.0% | 21,315 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $20,000 | -94.4% | 21,315 | -87.7% | 0.00% | -90.0% |
Q4 2019 | $354,000 | +45.7% | 173,415 | +104.5% | 0.02% | +25.0% |
Q3 2019 | $243,000 | +215.6% | 84,800 | +748.0% | 0.02% | +300.0% |
Q2 2019 | $77,000 | -42.1% | 10,000 | 0.0% | 0.00% | -50.0% |
Q1 2019 | $133,000 | -54.9% | 10,000 | -33.3% | 0.01% | -38.5% |
Q3 2018 | $295,000 | -46.9% | 15,000 | -22.7% | 0.01% | -50.0% |
Q2 2018 | $556,000 | -68.3% | 19,400 | -73.9% | 0.03% | -70.1% |
Q1 2018 | $1,756,000 | +105.1% | 74,300 | +85.8% | 0.09% | +107.1% |
Q4 2017 | $856,000 | +81.4% | 40,000 | +100.0% | 0.04% | +82.6% |
Q3 2017 | $472,000 | +700.0% | 20,000 | +566.7% | 0.02% | +666.7% |
Q2 2017 | $59,000 | +25.5% | 3,000 | +20.0% | 0.00% | 0.0% |
Q4 2016 | $47,000 | -28.8% | 2,500 | 0.0% | 0.00% | -25.0% |
Q3 2015 | $66,000 | – | 2,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |